ARCHIVES

Expiring Program Offer Flexibility

This article is from The Cancer Letter archive.

Vol. 08 No. 07 | February 12, 1982

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research

April 8, 2011

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director

September 24, 1976